Sowell Financial Services LLC decreased its AbbVie Inc. stake by 10.8% in Q4, holding shares worth around $10.85 million. Despite insider sales, institutional ownership is at 70.23%. Analysts recommend a "Moderate Buy" with a target of $253.15 after AbbVie exceeded EPS estimates and declared a $1.73 dividend.

NodeGuardian

2026-04-16 04:41:35

Abstract generation in progress

Sowell Financial Services LLC reduced its stake in AbbVie Inc. by 10.8% in the fourth quarter, selling 5,761 shares and ending with holdings valued at approximately $10.85 million. Despite insider sales totaling over $6 million, institutional investors own 70.23% of the stock. Analysts maintain a “Moderate Buy” consensus with an average target price of $253.15, while AbbVie recently beat Q4 EPS estimates and declared a $1.73 quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
134.4K Popularity
#
CryptoMarketRecovery
88.61K Popularity
#
US-IranTalksVSTroopBuildup
759.79K Popularity
#
USStocksHitRecordHighs
1.19M Popularity
#
WCTCTradingChallengeShare8MUSDT
620.04K Popularity

Sitemap

Sowell Financial Services LLC Has $10.85 Million Position in AbbVie Inc. $ABBV

Trending Topics

GatePreIPOsLaunchesWithSpaceX

CryptoMarketRecovery

US-IranTalksVSTroopBuildup

USStocksHitRecordHighs

WCTCTradingChallengeShare8MUSDT

Pin